DalsnaFinance › Analyst accuracy › Mizuho › RGNX target

Mizuho’s $22 target on RGNX

RGNX Regenxbio Inc
$7.76 → $22 (+184%) by Oct 2027
Outperform · initiates · said Oct 5, 2026 · 12-month default horizon
Open: judged on the close on Oct 5, 2027

The article this target came from

Mizuho initiates Regenxbio stock coverage with outperform rating

Investing.com · Oct 5, 2026
Mizuho initiated coverage on Regenxbio Inc. (NASDAQ:RGNX) with an outperform rating and set a price target of $22.00.

A fact about what Mizuho published, as reported by Investing.com, not a recommendation from Dalsna Finance; Mizuho is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.